Company / SG&A per Share
Amneal Pharmaceuticals, Inc. SG&A per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$2.99
FY2025
5-year range
$2.19 / $3.16
FY2021-FY2025
Trend
-5.2%
vs FY2024
Sector context
#64 of 210
Health Care
What the data says
At $2.99, Amneal Pharmaceuticals, Inc.'s sg&a per share ranks #147 of 210 in the Health Care sector. SG&A per Share has fluctuated over the past 9 years, ranging from $0.86 in FY2019 to $109046.00 in FY2017.
Based on SEC 10-K filings.
2.99 in FY2025 with a 5-year CAGR of +10.8%.
Increased from $2.41 to $2.99 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +3.7%
- 5-Year CAGR
- +10.8%
- 10-Year CAGR
- -
Sector benchmark
#147 of 210 in Health CareTop 70% of 210This company $2.99 Sector average $40.75
▼
-92.7% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share decreased 5.2% year-over-year.
- Ranks #64 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2017.
- Lowest sg&a per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.99 | -5.2% |
| FY2024 | $3.16 | +31.1% |
| FY2023 | $2.41 | -10.3% |
| FY2022 | $2.68 | +22.4% |
| FY2021 | $2.19 | +22.4% |
| FY2020 | $1.79 | +108.9% |
| FY2019 | $0.86 | -8.2% |
| FY2018 | $0.93 | -100.0% |
| FY2017 | $109046.00 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026